greeksoup/ stock research

Zoetis (ZTS) FY2023 results: revenue $8.5 billion, up 5.7% on the year

Zoetis Inc. (ZTS) reported revenue of $8.5 billion for fiscal 2023, the year ended 31 December 2023, up 5.7% on the year before. Net income was $2.3 billion, up 10.9%, and diluted earnings per share $5.07. The figures are the company's own, from the 10-K it filed with the SEC on 13 February 2024.

Revenue
$8.5 billion
+5.7% on the year
FY2016FY2023
Operating margin
n/a
FY2016FY2023
Net income
$2.3 billion
+10.9% on the year
FY2016FY2023
Diluted EPS
$5.07
+12.9% on the year
FY2016FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue8,5448,0807,776+5.7%
Cost of revenue2,5612,4542,303+4.4%
Gross profit5,9835,6265,473+6.3%
Gross margin70.0%69.6%70.4%
Research and development614539508+13.9%
Selling, general and administrative2,1512,0092,001+7.1%
Interest expense239221224+8.1%
Pre-tax income2,9362,6562,488+10.5%
Income tax596545454+9.4%
Effective tax rate20.3%20.5%18.2%
Net income2,3442,1142,037+10.9%
Net margin27.4%26.2%26.2%
Diluted EPS$5.07$4.49$4.27+12.9%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow2,3531,9122,213+23.1%
Capital expenditure732586477+24.9%
Free cash flow1,6211,3261,736+22.2%
Free cash flow margin19.0%16.4%22.3%
Cash from investing-777-883-458
Cash from financing-3,109-904-1,862
Depreciation and amortisation491465448+5.6%
Share-based compensation60.062.058.0-3.2%
Buybacks1,0921,594743-31.5%
Dividends paid692611474+13.3%
Dividend per share$1.56$1.35$1.07+15.3%
Diluted shares, weighted462m470m477m-1.7%
Shares outstanding at period end458m464m473m-1.2%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity4,9974,4054,543+13.4%
Non-controlling interest-6.0-2.01.0
Short-term borrowings3.02.00.0+50.0%
Debt6,5647,9026,592-16.9%
Operating lease liabilities188186151+1.1%
Finance lease liabilities8.00.0n/a
Other liabilities2,5322,4322,613+4.1%
Total liabilities and equity14,28614,92513,900-4.3%
Fixed assets3,2042,7532,422+16.4%
Goodwill2,7592,7462,682+0.5%
Intangible assets1,3381,3801,474-3.0%
Cash and equivalents2,0413,5813,485-43.0%
Receivables1,3041,2151,133+7.3%
Inventory2,5642,3451,923+9.3%
Other assets1,076905781+18.9%
Total assets14,28614,92513,900-4.3%

10-K for the year ended 31 December 2023, filed 13 February 2024: the filing.